Evidence map›Paper›PMID 31221195›Full record

ArticleBMC research notes2019

Mycobacterium tuberculosis detection from oral swabs with Xpert MTB/RIF ULTRA: a pilot study.

Annelies W Mesman, Roger Calderon, Martin Soto, Julia Coit, Juan Aliaga, Milagros Mendoza, Molly F Franke

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMC research notes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04923958 (Rapid Research in Diagnostics Development for TB Network), which is not on this map. Cited by 39 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 5 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04923958 narecruitingnot on this mapstarted 2021, after this paper: background citation

Rapid Research in Diagnostics Development for TB Network (R2D2 TB Network) Study

TypeinterventionalSponsorUniversity of California, San FranciscoRan2021 to 2031Enrolled26,436ConditionsTuberculosisArmsNovel mycobacterial culture techniques, Novel sputum smear microscopy techniques, Sputum-based molecular assays, Tongue swab-based molecular assays, Urine LAM assays
3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 5 syntheses or guidelines pooled it, 54 citations in OpenAlex.

  1. Revolutionizing diagnosis of pulmonaryFrontiers in microbiology · 2024
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Evaluating the efficacy of stool sample on Xpert MTB/RIF Ultra and its comparison with other sample types by meta-analysis for TB diagnostics.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2022
    Pooled it
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. High-sensitivity detection ofJournal of clinical microbiology · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. High-sensitivity detection ofmedRxiv : the preprint server for health sciences · 2024
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Annelies W MesmanDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, USA. annelies_mesman@hms.harvard.edu.ORCID http://orcid.org/0000-0002-4539-0140
Roger CalderonSocios En Salud Sucursal, Lima, Peru.
Martin SotoSocios En Salud Sucursal, Lima, Peru.
Julia CoitDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, USA.
Juan AliagaSocios En Salud Sucursal, Lima, Peru.
Milagros MendozaSocios En Salud Sucursal, Lima, Peru.
Molly F FrankeDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, USA.
EsSALUD · PEHarvard University · US

Funding

Sequencing CoreU19AI109755 · NIAID · HARVARD MEDICAL SCHOOL · PI CHANDLER, DARRELL P, CULHANE, AEDIN C · 2014 to 2018
$29.1M
NIAID NIH HHS U19 AI109755NIH HHS U19 AI109755
6 · The paper itself

Abstract

objectiveDiagnostic testing for tuberculosis depends on microbiological detection of Mycobacterium tuberculosis (Mtb) in sputum. For patients unable to expectorate sputum, such as children and individuals living with HIV, this poses barriers to rapid diagnosis and treatment initiation. Therefore, this study aimed to use oral swabs as an alternative sample type for Mtb detection via molecular testing.

resultsIn a pilot study, we aimed to evaluate sensitivity of Mtb detection via oral swabs using Xpert MTB/RIF ULTRA. We enrolled 33 TB cases and 30 controls from Lima, Peru, and detected Mtb from oral swabs with a sensitivity of 45% (95% confidence interval (CI) 29-62%) and specificity of 100% (95% CI 89-100%) using liquid culture of sputum as reference test. Our current protocol will need optimization, but these results support future exploration of the use of oral swabs for Mtb detection.

Indexed as

Reagent Kits, DiagnosticAdultHumansMouthMycobacterium tuberculosisPilot ProjectsRifampinTuberculosisReagent Kits, DiagnosticRifampinBuccal swabMolecular diagnosticsSample typeXpert

Identifiers

PMID31221195
PMCPMC6585073
OpenAlexW2951398589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.